Merck & Co. Inc. (MRK)

$ 129.48
   
  • Change Today:
    $0.11
  • 52 Week High: $131.95
  • 52 Week Low: $100.18
  • Currency: US Dollars
  • Shares Issued: 2,531.63m
  • Volume: 7,338,462
  • Market Cap: $327,796m
  • RiskGrade: 92

Merck starts third phase clinical trial to evaluate Covid-19 treatment molnupiravir

By Alexander Bueso

Date: Wednesday 20 Oct 2021

LONDON (ShareCast) - (Sharecast News) - Merck and its Miami-based partner Ridgeback Biotherapeutics have started the third phase of its MOVEe-AHEAD clinical trial for molnupiravir, an investigational oral antiviral therapeutic against infection from Covid-19.
According to Dr. Nick Kartsonis, senior vice-president vaccines and infectious diseases at Merck, "as the pandemic continues to evolve and surges are being reported in many places around the world, it is important that we investigate new ways to protect individuals exposed to the virus from becoming infected with symptomatic disease."

The third phase of the clinical trial would evaluate the efficacy of the treatment in adults from households where someone had been confirmed as having symptomatic Covid-19.

Molnupiravir was already under evaluation in the second part of the same phase three trial for patients with laboratory-confirmed mild to moderate Covid-19 plus at least one risk factor linked to "poor" disease outcomes.

As of 1250 BST, shares of Merck were rising by 0.34% to $76.55.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Merck Market Data

Currency US Dollars
Share Price $ 129.48
Change Today $ 0.11
% Change 0.09 %
52 Week High $131.95
52 Week Low $100.18
Volume 7,338,462
Shares Issued 2,531.63m
Market Cap $327,796m
RiskGrade 92

What The Brokers Say

Strong Buy 11
Buy 12
Neutral 3
Sell 0
Strong Sell 0
Total 26
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 14-Jun-2024

Time Volume / Share Price
16:00 1,212,507 @ $129.48
15:59 200 @ $129.48
15:59 500 @ $129.48
15:59 200 @ $129.48
15:59 100 @ $129.50

Top of Page